Your browser doesn't support javascript.
loading
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Rejeski, Kai; Subklewe, Marion; Aljurf, Mahmoud; Bachy, Emmanuel; Balduzzi, Adriana; Barba, Pere; Bruno, Benedetto; Benjamin, Reuben; Carrabba, Matteo G; Chabannon, Christian; Ciceri, Fabio; Corradini, Paolo; Delgado, Julio; Di Blasi, Roberta; Greco, Raffaella; Houot, Roch; Iacoboni, Gloria; Jäger, Ulrich; Kersten, Marie José; Mielke, Stephan; Nagler, Arnon; Onida, Francesco; Peric, Zinaida; Roddie, Claire; Ruggeri, Annalisa; Sánchez-Guijo, Fermín; Sánchez-Ortega, Isabel; Schneidawind, Dominik; Schubert, Maria-Luisa; Snowden, John A; Thieblemont, Catherine; Topp, Max; Zinzani, Pier Luigi; Gribben, John G; Bonini, Chiara; Sureda, Anna; Yakoub-Agha, Ibrahim.
Afiliação
  • Rejeski K; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Subklewe M; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Aljurf M; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Bachy E; Department of Hematology, Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France.
  • Balduzzi A; Pediatric Transplantation Unit, Department of Medicine and Surgery, University of Milan-Bicocca-Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Barba P; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Bruno B; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Benjamin R; Division of Hematology and Cell Therapy Unit, Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Carrabba MG; School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Chabannon C; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Milan, Italy.
  • Ciceri F; Institut Paoli-Calmettes Comprehensive Cancer Centre and Module Biothérapies du Centre d'Investigations Cliniques de Marseille, INSERM-Aix-Marseille Université-AP-HM-IPC, CBT-1409, Marseille, France.
  • Corradini P; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Milan, Italy.
  • Delgado J; Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Instituto Nazionale dei Tumori, University of Milan, Milan, Italy.
  • Di Blasi R; Oncoimmunotherapy Unit, Department of Hematology, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Greco R; Université de Paris, Assistance Publique-Hopitaux de Paris, Service d'hémato-oncologie, Paris, France.
  • Houot R; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Milan, Italy.
  • Iacoboni G; Department of Hematology, CHU Rennes, University of Rennes, INSERM U1236, Rennes, France.
  • Jäger U; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Kersten MJ; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Mielke S; Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Nagler A; Department of Hematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Onida F; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Department of Laboratory Medicine and Medicine Huddinge, Karolinska University Hospital and Institute, Stockholm, Sweden.
  • Peric Z; Division of Hematology, Chaim Sheba Medical Center, Tel Aviv University, Tel-Hashomer, Israel.
  • Roddie C; Hematology and Bone Marrow Transplantation Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
  • Ruggeri A; Department of Hematology, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Sánchez-Guijo F; Department of Hematology, University College London Hospital, London, United Kingdom.
  • Sánchez-Ortega I; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Milan, Italy.
  • Schneidawind D; University of Salamanca, IBSAL-University Hospital of Salamanca, Salamanca, Spain.
  • Schubert ML; Executive Office, European Society for Blood and Marrow Transplantation, Barcelona, Spain.
  • Snowden JA; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Thieblemont C; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Topp M; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Zinzani PL; Université de Paris, Assistance Publique-Hopitaux de Paris, Service d'hémato-oncologie, Paris, France.
  • Gribben JG; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Bonini C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli," Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
  • Sureda A; Barts Cancer Institute, Queen Mary, University of London, London, United Kingdom.
  • Yakoub-Agha I; Division of Immunology, Transplantation and Infectious Disease, Experimental Hematology Unit, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
Blood ; 142(10): 865-877, 2023 09 07.
Article em En | MEDLINE | ID: mdl-37300386
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Hematologia Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Hematologia Idioma: En Ano de publicação: 2023 Tipo de documento: Article